Pfizer nearing 100% Seagen purchase

By Agence France-Presse

Dec 14, 2023 12:16 am

NEW YORK CITY: Pfizer announced on Tuesday that it expects to complete this week its $43-billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.

'Pfizer and Seagen have now received all required regulatory approvals,' Pfizer said in a news release that reported a key US antitrust waiting period had expired. 'Pfizer expects to close the acquisition of Seagen on December 14.'

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Meta plans to invest $60-B or more in AI this year

WTO chief warns of tit-for-tat tariffs

SG central bank eases its monetary policy

Mitsubishi mulls foregoing Nissan-Honda merger

Bank of Japan hikes interest rate

Boeing warns Q4 loss bigger than expected

CNN eyes 200 job cuts